Novel Protein Design Strategy Aimed At Developing Long-acting Medications For Severe Bleeding Disorders

A new technology for design of proteins could mean that boys and men with bleeding disorders no longer need to receive treatment as frequently as they do today. "This could have significant implications for patients and their families," says professor Jan Terje Andersen.

Image of the two researchers in the lab

Postdoctoral researcher Jeannette Nilsen (left) and postdoctoral researcher Kristin Hovden Aaen are two of the scientists who have contributed to designing the modified proteins using new technology and biological insights. Image: Daniela Bejan

By

Elin Martine Doeland

/University of Oslo Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.